Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

4.65
Delayed Data
As of Dec 09
 -0.15 / -3.12%
Today’s Change
3.20
Today|||52-Week Range
29.86
-80.75%
Year-to-Date
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Dec 06 / MotleyFool.com - Paid Partner Content
Why These 3 Healthcare Stocks Lost Half Their Value in November
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.80
Today’s open4.80
Day’s range4.60 - 5.00
Volume1,921,000
Average volume (3 months)1,967,799
Market cap$179.2M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+1.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
ABUSArbutus Biopharma Co...+0.10+3.17%
OCXOncoCyte Corp+0.05+0.82%
ITEKInotek Pharmaceutica...-0.15-2.16%
DRRXDURECT Corp-0.05-3.62%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts


Search for Jobs